143 related articles for article (PubMed ID: 8315554)
1. Vitamin K1 concentration in breast-fed neonates after oral or intramuscular administration of a single dose of a new mixed-micellar preparation of phylloquinone.
Schubiger G; Tönz O; Grüter J; Shearer MJ
J Pediatr Gastroenterol Nutr; 1993 May; 16(4):435-9. PubMed ID: 8315554
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tolerance of intravenous and intramuscular phylloquinone (vitamin K1) mixed micelles formulation.
Soedirman JR; De Bruijn EA; Maes RA; Hanck A; Grüter J
Br J Clin Pharmacol; 1996 Jun; 41(6):517-23. PubMed ID: 8799516
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations after oral or intramuscular vitamin K1 in neonates.
McNinch AW; Upton C; Samuels M; Shearer MJ; McCarthy P; Tripp JH; L'E Orme R
Arch Dis Child; 1985 Sep; 60(9):814-8. PubMed ID: 4051538
[TBL] [Abstract][Full Text] [Related]
4. Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding.
Pereira SP; Shearer MJ; Williams R; Mieli-Vergani G
Arch Dis Child Fetal Neonatal Ed; 2003 Mar; 88(2):F113-8. PubMed ID: 12598499
[TBL] [Abstract][Full Text] [Related]
5. A new mixed micellar preparation for oral vitamin K prophylaxis: randomised controlled comparison with an intramuscular formulation in breast fed infants.
Greer FR; Marshall SP; Severson RR; Smith DA; Shearer MJ; Pace DG; Joubert PH
Arch Dis Child; 1998 Oct; 79(4):300-5. PubMed ID: 9875038
[TBL] [Abstract][Full Text] [Related]
6. Oral vitamin K1 prophylaxis for newborns with a new mixed-micellar preparation of phylloquinone: 3 years experience in Switzerland.
Schubiger G; Stocker C; Bänziger O; Laubscher B; Zimmermann H
Eur J Pediatr; 1999 Jul; 158(7):599-602. PubMed ID: 10412823
[TBL] [Abstract][Full Text] [Related]
7. Plasma vitamin K1 and PIVKA-II after oral administration of mixed-micellar or cremophor EL-solubilized preparations of vitamin K1 to normal breast-fed newborns.
Schubiger G; Grüter J; Shearer MJ
J Pediatr Gastroenterol Nutr; 1997 Mar; 24(3):280-4. PubMed ID: 9138173
[TBL] [Abstract][Full Text] [Related]
8. The bioavailability of a mixed micellar preparation of vitamin K1, and its procoagulant effect in anticoagulated rabbits.
Winn MJ; White PM; Scott AK; Pratt SK; Park BK
J Pharm Pharmacol; 1989 Apr; 41(4):257-60. PubMed ID: 2568466
[TBL] [Abstract][Full Text] [Related]
9. [Vitamin K 1 concentration and vitamin K-dependent clotting factors in newborn infants after intramuscular and oral administration of vitamin K 1].
Goldschmidt B; Kisrákói C; Téglás E; Verbényi M; Kovács I
Orv Hetil; 1990 Jun; 131(24):1297-300. PubMed ID: 2195426
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations after intravenous administration of phylloquinone (vitamin K(1)) in preterm and sick neonates.
Raith W; Fauler G; Pichler G; Muntean W
Thromb Res; 2000 Sep; 99(5):467-72. PubMed ID: 10973675
[TBL] [Abstract][Full Text] [Related]
11. Prevention of vitamin K deficiency bleeding with oral mixed micellar phylloquinone: results of a 6-year surveillance in Switzerland.
Schubiger G; Berger TM; Weber R; Bänziger O; Laubscher B;
Eur J Pediatr; 2003 Dec; 162(12):885-8. PubMed ID: 14576936
[TBL] [Abstract][Full Text] [Related]
12. Vitamin K status of lactating mothers, human milk, and breast-feeding infants.
Greer FR; Marshall S; Cherry J; Suttie JW
Pediatrics; 1991 Oct; 88(4):751-6. PubMed ID: 1896278
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease.
Pereira SP; Rowbotham D; Fitt S; Shearer MJ; Wendon J; Williams R
J Hepatol; 2005 Mar; 42(3):365-70. PubMed ID: 15710219
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of oral administration of a micellaar solution of vitamin K during the neonatal period].
Maurage C; Dalloul C; Moussa F; Cara B; Dudragne D; Lion N; Amédée-Manesme O
Arch Pediatr; 1995 Apr; 2(4):328-32. PubMed ID: 7780540
[TBL] [Abstract][Full Text] [Related]
15. VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation.
Marinova M; Lütjohann D; Breuer O; Kölsch H; Westhofen P; Watzka M; Mengel M; Stoffel-Wagner B; Hartmann G; Coch C; Oldenburg J
Eur J Clin Pharmacol; 2013 Mar; 69(3):467-75. PubMed ID: 22864379
[TBL] [Abstract][Full Text] [Related]
16. Vitamin K1 (phylloquinone) and vitamin K2 (menaquinone) status in newborns during the first week of life.
Greer FR; Mummah-Schendel LL; Marshall S; Suttie JW
Pediatrics; 1988 Jan; 81(1):137-40. PubMed ID: 3336580
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of phylloquinone from an intravenous lipid emulsion.
Camilo ME; Jatoi A; O'Brien M; Davidson K; Sokoll L; Sadowski JA; Mason JB
Am J Clin Nutr; 1998 Apr; 67(4):716-21. PubMed ID: 9537619
[TBL] [Abstract][Full Text] [Related]
18. Vitamin K, an update for the paediatrician.
Van Winckel M; De Bruyne R; Van De Velde S; Van Biervliet S
Eur J Pediatr; 2009 Feb; 168(2):127-34. PubMed ID: 18982351
[TBL] [Abstract][Full Text] [Related]
19. Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants.
Cornelissen EA; Kollée LA; De Abreu RA; van Baal JM; Motohara K; Verbruggen B; Monnens LA
Arch Dis Child; 1992 Oct; 67(10):1250-4. PubMed ID: 1444522
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations of vitamin K1 and PIVKA-II in bottle-fed and breast-fed infants with and without vitamin K prophylaxis at birth.
Widdershoven J; Lambert W; Motohara K; Monnens L; de Leenheer A; Matsuda I; Endo F
Eur J Pediatr; 1988 Nov; 148(2):139-42. PubMed ID: 3234435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
